. Author manuscript; available in PMC: 2016 Nov 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2015 Jul 14;21(11):1948–1954. doi: 10.1016/j.bbmt.2015.07.005

Table 2.

Myeloid and T-lymphocyte chimerism at day +90 to +120 according to disease status at transplant.

	CR1/CR2	Non-CR1/CR2	P
% Donor T-lymphocyte chimerism	N=164 (%)	N=101 (%)
100	70 (43%)	61 (60%)	.005
86-99	49 (30%)	21 (21%)	Ref.
≤85	45 (27%)	19 (19%)	Ref.
% Donor myeloid chimerism	N=179 (%)	N=107 (%)
100	120 (67%)	80 (75%)	.2
99	44 (25%)	13 (12%)	Ref.
≤98	15 (8%)	14 (13%)	Ref.

Ref. indicates reference.